THE VACCINE PRINCE BETS ON A SECOND CHANCE.

The article discusses the leadership demonstrated by Adar Poonawalla, chief executive officer (CEO) of Serum Institute of India (SII), with regard to the production of coronavirus disease 2019 (COVID-19) vaccines by SII. Topics explored include the partnership formed by SII with the University of Oxford and pharmaceutical firm AstraZeneca, factors which led to the failure of SII to contribute to the global COVID-19 vaccine supply, and the response of SII to the domestic vaccine demand of India.